- English version
- Articles
- Life Sciences
- Biomedicine
- Monocytes facilitate the manifestations of Alzheimer's disease
Related posts
-
Will blocking interleukin-10 help with Alzheimer's disease?
In the absence of this cytokine, the body's immune system is able to clear the brain of toxic plaques, which are a characteristic sign of Alzheimer's disease, and reverse the process of memory loss and damage to neurons.
12 February 2015 -
Alzheimer's disease: a paradigm shift?
Researchers from the Stanford University School of Medicine have proposed a fundamentally new hypothesis of the causes of Alzheimer's disease.
16 August 2013 -
Alzheimer's disease: another promising approach
Increasing the expression of the Scara1 protein is a promising approach to the treatment of Alzheimer's disease. This could potentially lead to the development of methods to use the immune system to delay the progression of the disease.
09 July 2013 -
Suppressing the immune response will help with Alzheimer's disease?
Inactivation of the immune complex, which triggers inflammatory reactions in brain tissue, suppresses the course of Alzheimer's disease.
26 December 2012 -
Gamma antibodies against diabetes and Alzheimer's and Parkinson's diseases
The new antibodies are uniquely effective in preventing the formation of toxic protein particles involved in the development of Alzheimer's disease, Parkinson's disease and type 2 diabetes mellitus.
07 December 2012